One Kansas City priest is especially thankful he's able to continue his calling this American Heart Month, thanks to a new ...

Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications like ...

Obesity, diabetes and high blood pressure are fueling increases in cardiovascular disease, even among much younger women, the ...

Cytokinetics, Incorporated CYTK announced that the European Commission (EC) has approved Myqorzo (aficamten), 5 mg, 10 mg, 15 ...

Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new study. Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to ...

Cardiac amyloidosis is a progressive condition that affects the heart and other organs, but new FDA-approved drugs are prolonging the lives of those affected and early identification is now possible.

An analysis of cardiac arrest records in a U.S. registry revealed that people with drug overdose cardiac arrests were more likely to be younger, have fewer health conditions and have higher survival ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform that enables the automated production of 3D cardiac ...